Clinical Trial Update: Safinamide Renal Impairment Trial [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safinamide in participants with renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• Safinamide (Safinamide)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED